Press Releases

ITUS Subsidiary Anixa Diagnostics Corporation Appoints Dr. Michael Shepard to Its Scientific Advisory Board

December 7, 2015

ITUS Subsidiary Anixa Diagnostics Corporation Announces Initial Cancer Biomarker Results

October 5, 2015

ITUS Subsidiary Anixa Diagnostics Enters Into Collaborative Research Agreement With The Wistar Institute, a Leading Cancer Research Institute

July 14, 2015

ITUS Announces Uplisting to NASDAQ

July 9, 2015

ITUS Announces Reverse Stock Split With the Intention to List Shares on NASDAQ

June 25, 2015

ITUS Announces Formation of Cancer Diagnostics Subsidiary

June 23, 2015

ITUS Releases Operating Results for Fiscal 2014

January 29, 2015

Latest News & Events

Apr 17, 2019

US Patent & Trademark Office Issues Patent on Anixa Biosciences CAR-T Cancer Treatment Technology

Read More...

Apr 11, 2019

Anixa Biosciences Extends and Expands its Collaboration with New Jersey Urology

Read More...

Apr 3, 2019

Anixa Biosciences Presents Cchek™ Prostate Cancer Detection Data at AACR Annual Meeting

Read More...

Cancer Fact: Liver cancer accounts for 3.6% of worldwide cancer incidences.